Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.50
Bid: 220.00
Ask: 221.50
Change: -1.50 (-0.68%)
Spread: 1.50 (0.682%)
Open: 220.50
High: 221.50
Low: 220.50
Prev. Close: 222.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board

Mon, 26th Apr 2021 16:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Ebiquity PLC - marketing and media consultancy - Appoints Lara Izlan as non-executive director with effect on June 1. Is currently director of Data Strategy at FTSE-250 listed broadcaster ITV PLC.

----------

Arix Bioscience PLC - firm which invests in biotech companies - Acacia Research Corp, a 19% shareholder in Arix will requisition resolutions for Arix's annual general meeting, nominating the appointment of Peregrine Moncreiffe, Issac Kohlberg and Maureen O'Connell to the company's board. Moncreiffe is chair of North Atlantic Smaller Companies Investment Trust PLC and Kohlberg is chief technology development officer for Harvard University.

----------

PureTech Health PLC - clinical-stage biotherapeutics company - Founded entity Gelesis appoints Jane Wildman to board of directors, as it looks to launch its commercial product Plenity in the US. Most recent executive role was as president of personal care consumer products firm Combe Inc, and Wildman has also spent 25 years at Procter & Gamble Co for 25 years from 1983 to 2009.

----------

All Active Asset Capital Ltd - London-based firm seeking investment opportunities in the technology, software and artificial intelligence space - Intends to appoint Frank Cho and Kassir Kayani as managing directors, roles outside of the company's board. Appointments are subject to formal administrative and regulatory requirements. Cho's most recent role is as global agency lead in Business Planning & Operations for Facebook Inc, while Kayani is chief technology officer at CSL Group, a company in the fire and security sector.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Jul 2021 18:06

Johnson & Johnson colon inflammation drug sees 55% remission rates

Johnson & Johnson colon inflammation drug sees 55% remission rates

Read more
7 Jul 2021 22:11

TRADING UPDATES: Cohort wins Italian navy contract; Beximco waits

TRADING UPDATES: Cohort wins Italian navy contract; Beximco waits

Read more
30 Jun 2021 19:14

TRADING UPDATES: Topps Tiles improves as curbs ease; Bermele makes buy

TRADING UPDATES: Topps Tiles improves as curbs ease; Bermele makes buy

Read more
28 Jun 2021 13:55

IN BRIEF: Director Scardino buys 10,000 PureTech Health shares

IN BRIEF: Director Scardino buys 10,000 PureTech Health shares

Read more
24 Jun 2021 21:44

DIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells

DIRECTOR DEALINGS: Melrose non-exec buys shares; TBC director sells

Read more
23 Jun 2021 17:25

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

TRADING UPDATES: Marlowe turns to loss; AFC Energy sees maiden revenue

Read more
16 Jun 2021 14:23

IN BRIEF: PureTech buys remaining 22% stake in Alivio Therapeutics

IN BRIEF: PureTech buys remaining 22% stake in Alivio Therapeutics

Read more
26 May 2021 18:03

IN BRIEF: PureTech Health's Akili secures USD160 million in financing

IN BRIEF: PureTech Health's Akili secures USD160 million in financing

Read more
15 Apr 2021 11:54

TRADING UPDATES: Serica production slips; Epwin confident for future

TRADING UPDATES: Serica production slips; Epwin confident for future

Read more
15 Apr 2021 07:52

Puretech Health narrows FY operating losses after cutting expenses

(Sharecast News) - Biotechnology company Puretech Health said on Thursday that it had narrowed operating losses in 2020 on the back of a reduction in general and administrative expenses and a modest increase in full-year revenues.

Read more
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Apr 2021 14:48

IN BRIEF: PureTech Health's Akili to study AKL-T01 in Covid survivors

IN BRIEF: PureTech Health's Akili to study AKL-T01 in Covid survivors

Read more
26 Mar 2021 15:40

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

TRADING UPDATES: Contango in offtake talks for coking coal in Zimbabwe

Read more
18 Mar 2021 15:46

EXECUTIVE CHANGES: Sureserve executive chair departs after turnaround

EXECUTIVE CHANGES: Sureserve executive chair departs after turnaround

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.